328 related articles for article (PubMed ID: 26926561)
21. The appropriateness of a proton pump inhibitor prescription.
Moran N; Jones E; O'Toole A; Murray F
Ir Med J; 2014; 107(10):326-7. PubMed ID: 25551900
[TBL] [Abstract][Full Text] [Related]
22. Proton pump inhibitor prescribing patterns in the UK: a primary care database study.
Othman F; Card TR; Crooks CJ
Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1079-87. PubMed ID: 27255671
[TBL] [Abstract][Full Text] [Related]
23. Appropriateness of proton pump inhibitors prescription in patient admitted to hospital: An observational study.
Gendre P; Mocquard J; Huon JF
Ann Pharm Fr; 2023 Jun; 81(4):596-603. PubMed ID: 36375532
[TBL] [Abstract][Full Text] [Related]
24. Impact of clinical pharmacists' recommendations on a proton pump inhibitor taper protocol in an ambulatory care practice.
Bundeff AW; Zaiken K
J Manag Care Pharm; 2013 May; 19(4):325-33. PubMed ID: 23627578
[TBL] [Abstract][Full Text] [Related]
25. Low-Value Proton Pump Inhibitor Prescriptions Among Older Adults at a Large Academic Health System.
Mafi JN; May FP; Kahn KL; Chong M; Corona E; Yang L; Mongare MM; Nair V; Reynolds C; Gupta R; Damberg CL; Esrailian E; Sarkisian C
J Am Geriatr Soc; 2019 Dec; 67(12):2600-2604. PubMed ID: 31486549
[TBL] [Abstract][Full Text] [Related]
26. Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation.
Giannini EG; Crespi M; Djahandideh A; Demarzo MG; Moscatelli A; Bodini G; Furnari M; Marabotto E; Plaz Torres MC; Zentilin P; Savarino V
Dig Liver Dis; 2020 Aug; 52(8):862-868. PubMed ID: 32505566
[TBL] [Abstract][Full Text] [Related]
27. Inappropriate utilization of intravenous proton pump inhibitors in hospital practice--a prospective study of the extent of the problem and predictive factors.
Craig DG; Thimappa R; Anand V; Sebastian S
QJM; 2010 May; 103(5):327-35. PubMed ID: 20211846
[TBL] [Abstract][Full Text] [Related]
28. Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care.
Ahrens D; Behrens G; Himmel W; Kochen MM; Chenot JF
Int J Clin Pract; 2012 Aug; 66(8):767-773. PubMed ID: 22805269
[TBL] [Abstract][Full Text] [Related]
29. Reasons for initiation of proton pump inhibitor therapy for hospitalised patients and its impact on outpatient prescription in primary care.
Villamañán E; Ruano M; Lara C; Suárez-de-Parga JM; Armada E; Álvarez-Sala R; Pérez E; Herrero A
Rev Esp Enferm Dig; 2015 Nov; 107(11):652-8. PubMed ID: 26541654
[TBL] [Abstract][Full Text] [Related]
30. [Proton pump inhibitors in patients with liver cirrhosis - a survey among hepatologists in Germany].
Horvatits T; Drolz A; Wehmeyer M; Steib C; Trebicka J; Lohse AW; Kluwe J
Z Gastroenterol; 2019 Jun; 57(6):729-733. PubMed ID: 31170742
[TBL] [Abstract][Full Text] [Related]
31. A Study on the Status of Proton Pump Inhibitor Prescriptions Using Diagnosis Procedure Combination Data in Japan.
Sakata Y; Tsuruoka N; Takedomi H; Akutagawa T; Shimoda R; Esaki M; Fujimoto K
Digestion; 2020; 101(3):308-315. PubMed ID: 30840949
[TBL] [Abstract][Full Text] [Related]
32. A questionnaire on prescription patterns of proton pump inhibitors for hemodialysis patients in Japan.
Kawarazaki H; Nakashima A; Furusho M; Shimizu S; Nakata T
Clin Exp Nephrol; 2020 Jun; 24(6):565-572. PubMed ID: 32147803
[TBL] [Abstract][Full Text] [Related]
33. Trends in Oral Antibiotic, Proton Pump Inhibitor, and Histamine 2 Receptor Blocker Prescription Patterns for Children Compared With Adults: Implications for Clostridium difficile Infection in the Community.
Faden HS; Ma CX
Clin Pediatr (Phila); 2016 Jul; 55(8):712-6. PubMed ID: 26350427
[TBL] [Abstract][Full Text] [Related]
34. Inappropriate Medication Use and Cost Comparison Analysis of Proton Pump Inhibitors: Evidence from an Indian Tertiary Care Facility.
Venkataraman R; Rashid M; Shrestha H
Curr Drug Saf; 2020; 15(2):147-155. PubMed ID: 32160850
[TBL] [Abstract][Full Text] [Related]
35. Use of antacids, alginates and proton pump inhibitors: a survey of the general Danish population using an internet panel.
Lødrup A; Reimer C; Bytzer P
Scand J Gastroenterol; 2014 Sep; 49(9):1044-50. PubMed ID: 24874283
[TBL] [Abstract][Full Text] [Related]
36. Snapshot of proton pump inhibitors prescriptions in a tertiary care hospital in Switzerland: less is more?
Lenoir C; El Biali M; Luthy C; Grosgurin O; Desmeules JA; Rollason V
Int J Clin Pharm; 2019 Dec; 41(6):1634-1641. PubMed ID: 31664687
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization.
Thomas L; Culley EJ; Gladowski P; Goff V; Fong J; Marche SM
J Manag Care Pharm; 2010 Mar; 16(2):122-9. PubMed ID: 20178397
[TBL] [Abstract][Full Text] [Related]
38. Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal tract bleeding: effect of standardized guidelines on prescribing practice.
Yachimski PS; Farrell EA; Hunt DP; Reid AE
Arch Intern Med; 2010 May; 170(9):779-83. PubMed ID: 20458085
[TBL] [Abstract][Full Text] [Related]
39. Impact of pharmacy intervention on the use of proton-pump inhibitors in the hospital setting.
Atkins R; Smith L
Consult Pharm; 2013 Dec; 28(12):786-92. PubMed ID: 24322962
[TBL] [Abstract][Full Text] [Related]
40. Factors associated with the initiation of proton pump inhibitors in corticosteroid users.
Munson JC; Wahl PM; Daniel G; Kimmel SE; Hennessy S
Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):366-74. PubMed ID: 22278844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
